Health In Tech Inc (HIT) FinancialsHITHealth In Tech Inc

Evaluating the bottom line, Health In Tech Inc maintains a gross margin of 48.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -42.68%, while the net margin is -31.17%. These profitability ratios, combined with a Return on Equity (ROE) of -21.96%, provide a clear picture of how effectively HIT converts its operational activities into shareholder value.

In the context of the broader market, HIT competes directly with industry leaders such as ICG and AURE. With a market capitalization of $65.86M, it holds a leading position in the sector. When comparing efficiency, HIT's gross margin of 48.69% stands against ICG's -98.25% and AURE's 100.00%. Such benchmarking helps identify whether Health In Tech Inc is trading at a premium or discount relative to its financial performance.

The total revenue for Q2 2026 was $8.1 million, a 13.5% decline year-over-year, and the company reported a net loss of $2.5 million in Q2 2026, highlighting profitability challenges.